Tues., June 21st, 2022
8–9 AM
Featured Speaker:
Tassos Gianakakos - CEO, MyoKardia
---Please join us as Tassos discusses his journey from conception to acquisition. MyoKardia was acquired in 2020 by Bristol Myers Squibb for $13.1 Billion in Cash.
Via ZOOM
Return to AZBio.org
"AZBio" is a 501(c)6 non-profit organization
2828 N. Central Avenue, STE 1100D
Phoenix, Arizona 85004
(480) 779-8101
Copyright 2023: AZBio, the Arizona Bioindustry Association, Inc.
